EQS-AFR: Pentixapharm Holding AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements


Werte in diesem Artikel

EQS Preliminary announcement financial reports: Pentixapharm Holding AG / Preliminary announcement on the disclosure of financial statements
Pentixapharm Holding AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

03.11.2025 / 10:52 CET/CEST
Preliminary announcement of the publication of quarterly reports and quarterly/interim statements transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Werbung


Pentixapharm Holding AG hereby announces that the following financial reports shall be disclosed:

Report Type: Quarterly/ Interim statement within the 2nd half-year

Language: German
Date of disclosure: November 12, 2025
Address: https://www.pentixapharm.com/investors/reports

Language: English
Date of disclosure: November 12, 2025
Address: https://www.pentixapharm.com/investors/reports


03.11.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: Pentixapharm Holding AG
Robert-Rössle-Straße 10
13125 Berlin
Germany
Internet: https://www.pentixapharm.com/

 
End of News EQS News Service

Werbung

2222590  03.11.2025 CET/CEST

Aktuelle Pentixapharm Aktie News

Werbung

Pentixapharm Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Pentixapharm nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
26.06.26 Pentixapharm Kaufen BankM AG